Saturday 7 November 2026 Export VYGR’s income statement to Excel — free account

Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $40.4 million, down 49.5% from fiscal 2024.

Revenue: −70.0%
EPS: +14.9%
Free cash flow: +37.1%

Quarter to September 2026, against a year earlier

1.90 0.18 +10.47%

Follow VYGR

Alert me

Market cap: $106.0M
P/E: 0.0×
Fwd P/E: −1.0×
Dividend yield: —
F-score: 2/9
Altman Z: −0.74
Beneish M: −2.87
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(58.90%)	(54.09%)	(52.26%)	(48.29%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	3	3	2	2
ROA Full definition →	(44.92%)	(41.45%)	(40.74%)	(37.10%)
ROIC Full definition →	(249.55%)	(192.55%)	(247.40%)	0.00%
Return on Tangible Assets Full definition →	(97.34%)	(89.97%)	(82.29%)	(63.25%)
Average Days of Receivables Full definition →	62.13	33.41	16.45	17.29
Free Cash Flow per Share Full definition →	(1.77)	(2.01)	(2.18)	(2.30)
Free Cash Flow Full definition →	(109.19)	(121.42)	(129.94)	(135.06)
Capital Expenditures Full definition →	—	(0.85)	(1.95)	(2.60)
Other line items
Cash ROIC Full definition →	(45.14%)	(44.85%)	(41.23%)	(34.41%)
Accounts Receivable Turnover Full definition →	6.04	12.14	19.44	19.73
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	426.02%	343.77%	350.06%	333.57%
Selling, General and Administrative Expense of Revenue Full definition →	124.10%	96.31%	99.10%	92.99%
Share Based Compensation of Revenue Full definition →	43.99%	34.54%	37.27%	36.63%
Operating CF/Net income Full definition →	1.04	1.12	1.10	1.11
Depreciation/Fixed assets Full definition →	0.25	0.18	0.13	0.08
Capex/Depreciation Full definition →	0.00	(0.42)	(1.19)	(2.39)
Revenue per Share Full definition →	0.41	0.57	0.61	0.69
Operating CF per Share Full definition →	(1.77)	(1.99)	(2.15)	(2.26)
Capex per Share Full definition →	0.00	(0.01)	(0.03)	(0.04)
Capex to Sales Full definition →	0.00	0.02	0.05	0.06

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly